Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Jeffrey Hayzlett, C-SUITE NETWORK™, Emovid™, and Didit Launch "Voices of 250" Initiative to Mobilize America's Business Leaders for the Nation's 250th Anniversary

prnewswire.com
NOC LLY NDAQ

SKYX Will Supply its Plug & Play Technologies During a Renovation of a Marriott City Center Hotel in Durham, NC

globenewswire.com
SKYX

Treasure Global’s Subsidiary Tadaa Capital Acquires Cigar Secret to Develop an AI-Power Premium Lifestyle Membership Ecosystem

globenewswire.com
TGL

Truist hires Shimna Sameer as head of Truist Wealth

prnewswire.com
TFC

New Zealand's Gold and Antimony Renaissance Is Attracting Serious Capital. This Dual-Project Explorer Just Made Its Board Match Its Ambitions.

prnewswire.com
PPTA OGC

Morphy July 15-16 Automobilia, Petroliana & Soda Advertising Auction Tallies A Robust $1.6M

prnewswire.com
HOG F

MNDR Wins 2026 Technology for Good Award, Featuring Aiko in Its AI Intelligent Healthcare Ecosystem Ready to Announce with Confidence?

newsfilecorp.com
MNDR

MONDAY DEADLINE: AeroVironment, Inc. (AVAV) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

prnewswire.com
AVAV

Class Action Lawsuit Filed Against Calix, Inc. (CALX) - Recover Losses - Contact Levi & Korsinsky Before July 27, 2026

accessnewswire.com
CALX

New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition

globenewswire.com
ARTL
View all news →